Title:
APPLICATION OF PHOSPHODIESTERASE 4 INHIBITOR ZL-N-91 IN PREPARATION OF MEDICATIONS FOR LUNG CANCER PROLIFERATION AND METASTASIS
Document Type and Number:
WIPO Patent Application WO/2017/133713
Kind Code:
A1
Abstract:
Provided is an application of a new phosphodiesterase 4 (PDE4) inhibitor ZL-n-91 for medications for treating lung cancer proliferation and metastasis.
Inventors:
ZHAO ALLAN ZIJIAN (CN)
GONG SIJIA (CN)
LIN YAN (CN)
LI FANGHONG (CN)
LI XIAOXI (CN)
GONG SIJIA (CN)
LIN YAN (CN)
LI FANGHONG (CN)
LI XIAOXI (CN)
Application Number:
PCT/CN2017/078690
Publication Date:
August 10, 2017
Filing Date:
March 30, 2017
Export Citation:
Assignee:
GUANGZHOU SINOGEN BIOMEDICAL TECH LTD (CN)
International Classes:
A61K31/341; A61P35/00; A61P35/04
Other References:
TANG, HUIFANG ET AL.: "Action of a Novel PDE4 Inhibitor ZL-n-91 on Lipopolysa-Ccharide-Induced Acute Lung Injury", INTERNATIONAL IMMUNOPHARMACOLOGY, 31 December 2010 (2010-12-31), pages 406 - 410, XP026980489, ISSN: 1567-5769
SHEN, JIAN ET AL.: "Phosphodiesterase-4 and Cancer", CHEMISTRY OF LIFE, vol. 35, 31 December 2015 (2015-12-31), pages 350 - 356, XP009512228, DOI: 10.13488/j.smhx.20150309
See also references of EP 3412287A4
SHEN, JIAN ET AL.: "Phosphodiesterase-4 and Cancer", CHEMISTRY OF LIFE, vol. 35, 31 December 2015 (2015-12-31), pages 350 - 356, XP009512228, DOI: 10.13488/j.smhx.20150309
See also references of EP 3412287A4
Attorney, Agent or Firm:
NANJING SUGAO PATENT AND TRADEMARK FIRM (ORDINARY PARTNERSHION) (CN)
Download PDF: